JavaScript is disabled. Please enable to continue!

Mobile search icon
Media Centre >> News >> Amending Annex XIV to REACH Regulation

Amending Annex XIV to REACH Regulation

Sidebar Image

Eurofins newsflash Chemical

 

Europe

 

Amending Annex XIV to REACH Regulation

 

On 24th November 2021, the European Union (EU) published Regulation (EU) No 2021/2045 with an  amendment to, Annex XIV to Regulation (EC) No 1907/2006 of REACH, which entered in force on 13th  January 2022.

 

This amendment replaces the following information in the table in Annex XIV to REACH for entries 4-7:

 

Entry Nr

Substance

Intrinsic property(ies) referred to in Article 57

Transitional arrangements

Latest application date

Sunset date

‘4.

Bis(2-ethylhexyl) phthalate

(DEHP)

EC No: 204-211-0

CAS No: 117-81-7

Toxic for reproduction (category 1B)

Endocrine disrupting properties (Article 57(f) – human health)

Endocrine disrupting properties (Article 57(f) – environment)

(a) 21 August 2013 (*)

(b) By way of derogation from point (a):

14 June 2023 for uses in:

— food contact materials within the scope of Regulation (EC) No 1935/2004;

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing DEHP at or above 0.1 % and below 0.3 % weight by weight;

(c) By derogation of point (a):

27 November 2023 for uses in medical devices within the scope of Directives 90/385/EEC, 93/42/EEC and 98/79/EC.

(a) 21 February 2015 (**)

(b) By way of derogation from point (a):

14 December 2024 for uses in:

— food contact materials within the scope of Regulation (EC) No 1935/2004;

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing DEHP at or above 0.1 % and below 0.3 % weight by weight;

(c) By derogation of point (a):

27 May 2025 for uses in medical devices within the scope of Directives 90/385/EEC, 93/42/EEC and 98/79/EC.

5.

Benzyl butyl phthalate

(BBP)

EC No: 201-622-7

CAS No: 85-68-7

Toxic for reproduction (category 1B)

Endocrine disrupting properties (Article 57(f) – human health)

(a) 21 August 2013 (*)

(b) By way of derogation from point (a):

14 June 2023 for uses in:

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing BBP at or above 0.1 % and below 0.3 % weight by weight.

(a) 21 February 2015 (**)

(b) By way of derogation from point (a):

14 December 2024 for uses in:

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing BBP at or above 0.1 % and below 0.3 % weight by weight.

6.

Dibutyl phthalate

(DBP)

EC No: 201-557-4

CAS No: 84-74-2

Toxic for reproduction

(category 1B)

Endocrine disrupting properties (Article 57(f) – human health)

(a) 21 August 2013 (*)

(b) By way of derogation from point (a):

14 June 2023 for uses in:

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing DBP at or above 0.1 % and below 0.3 % weight by weight.

(a) 21 February 2015 (**)

(b) By way of derogation from point (a):

14 December 2024 for uses in:

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing DBP at or above 0.1 % and below 0.3 % weight by weight.

7.

Diisobutyl phthalate

(DIBP)

EC No: 201-553-2

CAS No: 84-69-5

Toxic for reproduction

(category 1B)

Endocrine disrupting properties (Article 57(f) – human health)

(a) 21 August 2013 (*)

(b) By way of derogation from point (a):

14 June 2023 for uses in mixtures containing DIBP at or above 0.1 % and below 0.3 % weight by weight.

(a) 21 February 2015 (**)

(b) By way of derogation from point (a):

14 December 2024 for uses in mixtures containing DIBP at or above 0.1 % and below 0.3 % weight by weight.